SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-21-011609
Filing Date
2021-02-25
Accepted
2021-02-25 16:00:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea136526-13ddiscover_owcphar.htm SC 13D 45104
  Complete submission text file 0001213900-21-011609.txt   46730
Mailing Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334
Business Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334 972-72-2608004
OWC Pharmaceutical Research Corp. (Subject) CIK: 0001431934 (see all company filings)

IRS No.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-84779 | Film No.: 21680128
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address PO BOX 6278 ST THOMAS VI 00804-6278
Business Address PO BOX 6278 ST THOMAS VI 00804-6278 340 7748800
Discover Growth Fund, LLC (Filed by) CIK: 0001762773 (see all company filings)

IRS No.: 660854607 | State of Incorp.: VI | Fiscal Year End: 1231
Type: SC 13D